Ruth Muñoz Risueño

Title: Ruth Muñoz Risueño: Innovator in Cancer Treatment

Introduction

Ruth Muñoz Risueño is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions. With a total of 5 patents to her name, her work focuses on combination therapies that enhance the efficacy of cancer treatments.

Latest Patents

One of her latest patents involves a combination therapy for treating cancer. This invention relates to a combination comprising an antineoplastic agent, such as an antimetabolite antineoplastic agent, and a type 1 serotonin receptor (HTR1) modulator, specifically a HTR1 antagonist. Additionally, the invention includes a pharmaceutical composition that combines this innovative therapy with a pharmaceutically acceptable excipient. The application of this combination and pharmaceutical composition is particularly aimed at the prevention and/or treatment of hematological malignancies.

Career Highlights

Ruth has worked with notable organizations such as Leukos Biotech, S.L. and the Fundació Institut De Recerca Contra La Leucèmia Josep Carreras. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.

Collaborations

Ruth has collaborated with esteemed colleagues, including Mari Carmen Lara Castillo and Amaia Etxabe Alberdi. These partnerships have further enriched her research and development efforts, leading to advancements in cancer treatment methodologies.

Conclusion

Ruth Muñoz Risueño stands out as an influential inventor in the realm of cancer treatment. Her innovative approaches and dedication to improving patient outcomes through combination therapies highlight her significant role in the medical field.